Kresmir Letinic

Managing Director

Easton Capital Investment Group

Joined: 2009

Office Phone:

(212) 702-0950


  Pro - Try 1 Week Free
 

    and access,

  •     43K PE/M&A Contacts
  •     +
  •     4.0K PE Firms
  •     3.1K M&A Advisors
  •     142K Transactions
  •     150K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Prior to joining Easton in 2009, Kresimir was a Howard Hughes Medical Institute Predoctoral Fellow at Yale University where he led multi-disciplinary research projects linked to the areas of neurology, cancer and diabetes. Kresimir also led the development of computational technologies for application in biomedical imaging. He first-authored papers published in leading academic journals, including Nature, Nature Neuroscience and PNAS. Kresimir previously worked at Fletcher Spaght Ventures, a venture capital fund, The Channel Group, a life sciences advisory firm, and Lesanne Life Sciences, a stroke diagnostic startup company. His expertise includes health information technology, biotech, diagnostics, and devices. Kresimir has helped build and continues to lead Easton's Healthcare IT practice. Kresimir is a board director and chief business officer in Medikly, a board director in Wildflower Health and a board observer in KitCheck, Precise Light Surgical, SolX, and WellTrackOne. He is also a class 15' Kauffman Fellow. Kresimir completed both his PhD in neuroscience and MBA at Yale University. He earned his MD at Zagreb University, Croatia.

Education

Yale University , Connecticut,
1 of 366

University of Zagreb
1 of 3

Yale University School of Management
1 of 13